Collects real-world data on cancer patients treated with radiotherapy
Gathers records of people with cancer who receive radiation treatment, without changing their care.
Plain-language title generated from the registry record
Registry title: E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
Key facts
- Where
- Graz, Linz, and Vienna, AustriaSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- How old is the patient who may join a trial?
Source: NCT03818503, who can take part
Where in Austria
- Medical University of Graz - Radio-oncologyGraz, AustriaTaking people
- Ordensklinikum Linz Barmherzige SchwesternLinz, AustriaTaking people
- Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH uniklinikenVienna, AustriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- European Organisation for Research and Treatment of Cancer - EORTC
- Trial code
- NCT03818503
- Record updated
- 21 March 2025
- Original description
The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.Read full original descriptionShow less
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.
Inclusion: Pathologically confirmed cancer; Written informed consent for E²-RADIatE according to applicable legal and ethical requirements; Planned use of radiotherapy; Eligibility of the patient confirmed for at least one cohort confirmed; Patients of 12 years and older.